Resource Logo
CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update

CANADA: Nunavut Undertakes Hepatitis Survey in Baffin, Kivalliq Regions


The Nunavut Department of Health, the Public Health Agency of Canada, and the University of Manitoba will conduct a voluntary survey among the Nunavummiut in the Baffin and Kivalliq regions to determine the prevalence of hepatitis B and C and to ascertain the effectiveness of the government’s hepatitis immunization program. Participants may agree to be part of the survey when they visit their local health center for routine tests that require blood samples. The Canadian government estimates that Inuit are seven times more likely to have hepatitis B than “non-aboriginal Canadians.”

Hepatitis B transmission occurs through blood, semen, vaginal fluids, or saliva. Less than one percent of hepatitis B-infected people die from the initial infection, and most people fight off the virus on their own. Approximately 1 in 10 hepatitis B-infected people becomes a chronic carrier of the disease. Symptoms of infection include decreased appetite, fatigue, fever, and nausea; hepatitis B can lead to liver damage (cirrhosis) and liver cancer. Although all Canadian children receive a three-dose immunization shortly after birth, many adults have not taken the vaccine series. The Nunavut sexual health strategy aims to increase immunization among adult Nunavummiut.

Pauktuutit, an Inuit women’s association, also has called for more surveillance and research into hepatitis C among the Inuit people. Although incidence of hepatitis C is low in Nunavut, Pauktuutit concerns include lack of education regarding hepatitis C transmission, which can pass from person to person through sharing needles and personal hygiene equipment like toothbrushes and razors. An estimated 242,500 Canadians have hepatitis C, which often causes no symptoms. Approximately 21 percent of hepatitis C-infected people do not know they have the virus.


Copyright © 2013 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

Information in this article was accurate in May 13, 2013. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.